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Abstract 36 
Spinal cord injury (SCI) is a common cause of disability, which often leads to sensorimotor cortex 37 
dysfunction above the spinal injury site. However, the cerebral regional effects on metabolic 38 
information after SCI have been little studied. Here, adult Sprague-Dawley rats were divided into acute 39 
and chronic treatment groups and sham groups with day-matched periods. The BBB (Basso, Beatti 40 
and Bresnahan) scores method was utilized to evaluate the changes in behaviors during the recovery 41 
of the animals, and the metabolic information was measured with the 1H-observed/13C-edited NMR 42 
method. Total metabolic concentrations in every region were almost similar in both treated groups. 43 
However, the metabolic kinetics in most regions in the acute group were significantly altered (p<0.05), 44 
particularly in the cortical area, thalamus and hippocampus (p<0.01). After long-term recovery, some 45 
metabolic kinetics were recovered, especially in the temporal cortex, occipital cortex and medulla. 46 
The metabolic kinetic changes revealed the alteration of metabolism and neurotransmission in 47 
different brain regions after SCI, which present evidence for the alternation of brain glucose oxidation. 48 
Therefore, this shows the significant influence of SCI on cerebral function and neuroscience research. 49 
This study also provides the theoretical basis for clinical therapy after SCI, such as mitochondrial 50 
transplantation.  51 
 52 
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Introduction 54 
Spinal cord injury (SCI) is a common neurological injury that is associated with functional 55 
deficits and is also a major cause of disability. In traumatic SCI, the primary insult damages cells and 56 
initiates a complex secondary injury cascade, which cyclically produces the death of neurons and glial 57 
cells, ischaemia and inflammation (1). Secondary injury, which occurs hours to months after the initial 58 
primary traumatic insult, contributes to metabolic stress and progressive tissue damage and serves as 59 
a prime target for therapeutic intervention (2). Although numerous neuroprotective, neural 60 
regenerative and rehabilitation exercise therapies have been translated from preclinical studies into 61 
clinical trials, to date, there are no efficient or reliable clinical treatments available for SCI patients. 62 
One potential reason holding back improvements in SCI therapy lies in current strategies which focus 63 
on local changes at the spinal injury site and neglect the intimate interconnection with the brain (3). 64 
In recent years, there has been increasing evidence that SCI leads to alterations in brain structure, 65 
function and metabolite, by direct effects of nerve damage, secondary mechanisms, and also by longer 66 
term injury consequences such as paralysis and neuropathic pain (4). Several studies have shown that 67 
SCI resulted in central nervous system injury and structural reorganization of the spine and brain (5, 68 
6). Cortical functional reorganization in the sensorimotor areas have been demonstrated in the later 69 
stages of SCI (7, 8). In addition, the deafferentation and loss of sensorimotor function after SCI not 70 
only directly impacts the sensorimotor system, but also influences other regions, such as the insular, 71 
cerebellar, medial prefrontal, anterior cingulate and temporal cortices, which are crucial for processing 72 
emotional information and modulating attentional states (9). SCI also induces multiple disturbances 73 
in the metabolic network, including oxidative stress, glycolysis, amino acid and lipid metabolism (10, 74 
11). Rapid release of excessive glutamate and other neurotransmitters that may directly contribute to 75 
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cellular damage has been observed following SCI (12). However, previous studies have mainly 76 
focused on the SCI site or local area, hence the cerebral regional effects on metabolic information after 77 
SCI have been little studied, such as metabolite concentrations and metabolic kinetics of 78 
neurotransmitters and some other energetically related neurochemicals. 79 
After SCI, mitochondria dysfunction occurred in the brain during the acute phase, followed by 80 
inflammatory response and ER stress aroused at subacute phase (13). While normal brain function 81 
requires a stable energy supply, disturbances in brain energy metabolism have been associated with 82 
neurological dysfunctions and cognitive impairment (14). Glucose is considered as the main substrate 83 
for neuronal energy metabolism in the mammalian brain (15). It has also been estimated that the 84 
cycling between glutamine (Gln) and glutamate (Glu) accounts for more than 80% of cerebral glucose 85 
consumption (16). The tight coupling between the Glu–Gln cycle and brain energetics is largely tied 86 
to the nearly 1:1 stoichiometry between glucose oxidation and the rate of astrocytic Glu uptake (17). 87 
Thus, it is valuable to investigate the imbalance of brain energy metabolism in neurons and astrocytes 88 
and explore the pathogenesis of neurological disorders after SCI (18). 89 
1H observed/13C-edited (POCE) nuclear magnetic resonance (NMR) technique is a promising 90 
approach for investigating the metabolic kinetics in astrocytes, specific neurons and their interactions 91 
(19). Metabolic information between neuronal and astrocytic interaction can be investigated by the 92 
POCE method combined with the infusion of 13C-labeled glucose/acetate (20-22). We hypothesized 93 
that SCI could produce lasting deficits in brain metabolism. Thus, the purpose of the present study 94 
was to evaluate the effect of SCI on regional metabolic concentrations and rates of turnover of 95 
glutamate, glutamine, and GABA (γ-aminobutyric acid) and other metabolites in the rat brain. The 96 
changes in metabolic information could reveal the influence on different brain regions, which could 97 
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present evidence for the alternation of regional cerebral glucose oxidation and cerebral function after 98 
SCI. Furthermore, this study could provide the theoretical basis for clinical therapy after SCI, such as 99 
mitochondrial transplantation. 100 
 101 
Methods 102 
Animals 103 
The experimental protocols were approved by the animal care and use committee in Wuhan 104 
Institute of Physics and Mathematics, the Chinese Academy of Sciences. In order to investigate the 105 
changes of metabolic information among different brain regions after spinal cord injury, the severe 106 
spinal cord injury (SCI) model was used in the current study. However, this surgery can cause great 107 
trauma to animals, with many postoperative complications such as urinary retention and high mortality. 108 
Due to their different physiological structures, there is a much higher mortality rate in male rats than 109 
in female rats, even when the bladder is messaged two or three times per day. Therefore, to save the 110 
number of animals, female rats are often used in this kind of studies (23-25).  111 
In the current study, 52 female adult Sprague-Dawley rats (n=12 for each group in the NMR study, 112 
and n=4 for the histology study) were ordered from VITAL RIVER (Beijing, China) and kept in SPF 113 
(Specific pathogen Free) animal residence (Wuhan, China). Rats were housed in plastic cages (three 114 
animals per cage) in a climate-controlled room with 12 h of light-dark illumination cycle at 25±1 ºC 115 
and relative 50 ± 10% humidity. During the experiment, all rats were allowed free access to laboratory 116 
standard food (Product No: 190011304, WQJX Biotech, Wuhan, China) and water. Due to failure 117 
related to animal surgery (n=3) and tail vein catheterization (n=4), seven of the 48 rats were not 118 
included in the data analysis. 119 
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Animal experiment 120 
At first, all animals were randomly divided into four equal groups: the acute SCI treatment group 121 
(three days after injury), chronic SCI treatment group (28 days after injury) and the sham controls with 122 
day-matched periods (without SCI). Each subject was given a unique identification number, and the 123 
information of the experimental group was blinded to the operators, which could potentially influence 124 
outcomes of the experimental groups. 125 
For animal surgery, a rat was anesthetized with 1% pentobarbital (i.p., 5mg/100g). A sagittal 126 
incision was made at the lower dorsal part of the thoracic segment to expose the T7-T9 vertebral plate 127 
and spinous processes. The T8 vertebral plate was cut and removed under a surgical microscope to 128 
expose the intact dura. The animal was transferred to beneath the IH impactor which was equipped 129 
with a 4 mm tip, and the incision site was centered. The SCI was induced by contusion (200 kdyne) to 130 
the exposed segment, resulting in a severe contusion injury. Then the muscle layers and skin layers 131 
were sutured together after contusion. Animals in the control group only suffered sagittal incision and 132 
laminectomy for spinal cord exposure, but without contusion by the impactor. After the operation, all 133 
animals were carefully monitored for their mental status, such as eating, drinking, urination, as well 134 
as edema and ulcers. A Water Gel pack and food pellets were provided at the bottom of the cage for 135 
up to 72 h after SCI. Penicillin was continuously injected at 100000 units/time/day up to 7 days. The 136 
bladder was massaged 2-3 times per day until recovery of spontaneous urinary function. At the end, 137 
two rats died during the operation procedures and one died from paralytic intestinal obstruction. 138 
 139 
Basso, Beattie, and Bresnahan (BBB) Locomotor Scale 140 
In order to assess the motor function, all animals in the chronic SCI group and its related control 141 
group were placed in an uninterrupted open field and allowed unrestricted movement. Rats were 142 
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allowed to move freely and scored for their ability to use their hindlimbs. A 21- point BBB locomotion 143 
scale was used based on the movement of joints, placement of paws and coordination of forepaw and 144 
hind limbs (26). The BBB scores were determined 0, 1, 2, 3 and 4 weeks post-SCI to assess recovery 145 
of locomotion in the chronic SCI treatment group. 146 
 147 
Perfusion and histology of the spinal cord 148 
Rats from sham (Acute) (n=2) and Acute SCI (n=2) groups were anesthetized with 1% 149 
pentobarbital (i.p., 6mg/100g), and transcardially perfused with 0.9% saline (~300 ml, room 150 
temperature), followed by buffered 4% formaldehyde solution. The spinal cord of the eighth thoracic 151 
segment was taken, fixed in 4% formaldehyde for 24 hours, then embedded with alcohol gradient 152 
dehydration and paraffin. The horizontal and transverse sections of the spinal cord were cut and stained 153 
with HE (Hematoxylin eosin staining) and Nissl (Nissl’s staining) for histopathology examination 154 
under a microscope (Leica, Wetzlar, Germany). 155 
 156 
Infusion techniques 157 
The metabolic kinetics were assessed with the 13C enrichment into different carbon positions of 158 
metabolites after the infusion of [1-13C] glucose. For this method, the higher enrichment of [1-13C] 159 
glucose in the blood could yield greater sensitivity for detection. Therefore, the rats were fasted 160 
overnight (15-18h) to reduce the endogenous unlabeled glucose level before the experimental day.  161 
On the experimental day, rats were initially anesthetized with 4.0-5.0% isoflurane mixed with air, 162 
and 1.5-2.5% isoflurane to maintain the anesthesia state. The adequate level of anesthesia was verified 163 
by a lack of withdrawal response to a foot pinch. Then, one lateral tail vein was catheterized with PE50 164 
tubing (Instech, PA, USA) for the infusion of [1-13C] glucose, and the tube was immobilized to the tail 165 
with adhesive paper tape. Then those animals were recovered for about 15 minutes until they showed 166 
free movement and normal grooming. The infusion line was connected to a swivel (Instech, PA, USA) 167 
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and suspended from the center of the cage to avoid entanglement of the line during the rat movement. 168 
The other end of the swivel was connected to the infusion pump (Fusion100, Chemyx, TX, USA) with 169 
PE50 tubing. After everything was set up, the animal was allowed to recover for another 15 min. Then, 170 
[1-13C] glucose was infused through the lateral tail vein following a former infusion protocol (22) and 171 
the infusion ceased after 20 minutes. During the whole procedure, the rat had freedom of movement 172 
in the cage (22). All animals were sacrificed by the head-focused microwave irradiation method (1kW, 173 
Tangshan Nanosource Microwave Thermal Instrument Manufacturing Co. Ltd., Heibei, P.R. China). 174 
Then a blood sample (~1 mL) was withdrawn and the brain was manually dissected into 11 different 175 
regions as described previously (22): cerebellum (CE), medulla (MED), midbrain (MID), thalamus 176 
(THA), hypothalamus (HYP), hippocampus (HP), striatum (STR), frontal cortex (FC), occipital cortex 177 
(OC), parietal cortex (PC), and temporal cortex (TC). The tissue was weighed, frozen in liquid nitrogen, 178 
and stored at -80℃  until further processing. Four rats failed due to very low [1-13C] glucose 179 
enrichment (<10%), caused by the failure of tail vein catheterization. Thus, the cerebral data from 180 
these animals were ignored. Therefore, there were 41 rats that successfully completed the study, 181 
including 20 rats from the two separate control groups (10 by 10) and 21 rats from the two SCI groups 182 
(9 for acute SCI and 12 for Chronic SCI). 183 
 184 
Sample collection and preparation 185 
The preparation of brain tissue extracts was conducted using the same methanol-ethanol 186 
extraction method which was described in our previous work (27). Briefly, HCl/methanol (80 μL, 0.1 187 
M) was added to the brain samples, and the tissues were initially homogenized with Tissuelyser 188 
(Tissuelyser II, QIAGEN, German) for 90s at a frequency of 20 Hz. Then, 400 μL ethanol (60%, 189 
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vol/vol) was added to the mixture and the mixture was homogenized again under the same conditions. 190 
The homogenate was centrifuged at 14000 g for 15 min and the supernatant was collected. The entire 191 
extraction procedure was repeated twice with 1200 μL 60% ethanol. All the supernatants were 192 
collected and lyophilized with the centrifugal drying apparatus (Thermo Scientific 2010, Germany) 193 
after removing the organic solvent (ethanol and methanol) in the vacuum under normal temperature. 194 
The lyophilized products were re-dissolved in phosphate buffer (600µL D2O with 0.2 M 195 
Na2HPO4/NaH2PO4, pH=7.2). The solution was mixed evenly with a high-speed vortex and 196 
centrifuged at 14000 g for 15 min, and the supernatant (500 μL) was transferred to a 5 mm NMR tube 197 
for 1H-NMR analysis. 198 
 199 
Acquisition of NMR spectra 200 
All NMR spectra were acquired in a random order at 298 K using a BrukerAvance III 600 MHz 201 
NMR vertical bore spectrometer (BrukerBiospin, Germany). The samples were detected with POCE 202 
(Proton observed carbon editing, 1H -[13C]-NMR) pulse sequence which has been widely used for 13C 203 
enrichment in different positions of metabolites after infusion of 13C labeled chemical tracer (21). 204 
Briefly, this method consists of two spin-echo measurements, one without a broad-banded inversion 205 
pulse applied at the 13C frequency (total metabolites concentrations, 12C+13C), and the other one with the 206 
inversion pulse (the difference of the proton signals which connected with 12C and 13C in the metabolites, 207 
12C-13C). Thus, the subtraction between these two yields only 13C-labeled metabolites of the spectra. The 208 
following acquisition parameters were used: number of scans - 64; repetition time – 20 s; sweep width 209 
- 20 ppm; acquisition data - 64 K; echo time-8 ms. 210 
 211 
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NMR Spectra Processing 212 
All FID signals of 1H-NMR spectra were converted and the phase and baseline correction were 213 
manually performed in the commercial software Topspin 2.1 (Bruker Biospin, GmbH, Rheinstetten, 214 
Germany). Then the spectra was automatically processed with a home-made software NMRSpec (28) 215 
in MATLAB (Freely available from the author upon request: jie.wang@wipm.ac.cn).  216 
Relative concentration calculation 217 
At first, the phase and baseline corrected POCE spectra were loaded into NMRSpec. Then the 218 
peak alignment, integrations of peaks and chemical related peaks were automatically completed. The 219 
extract ratio for a sample was an unpredicted value, and it was hardly the same as the others. Therefore, 220 
it was better to complete the normalization before further analysis. All peak areas and spectra data 221 
were normalized with the conventional probabilistic quotient normalization (PQN) method (29), 222 
which has been widely used in metabolomics research (30, 31). For the relative concentration 223 
calculation, the average chemical related peak area in the Sham (Acute) group was set as reference ‘1’, 224 
then the relative concentrations of this metabolite in every sample was calculated from the quotient 225 
between the same location of the NMR spectrum and that averaged peak area. Then the average 226 
concentration and standard error of various metabolites in different experimental groups were 227 
calculated according to the method described above. 228 
Metabolic enrichment calculation 229 
The 13C related NMR spectrum was obtained by subtracting the two spin-echo measurements in 230 
the POCE spectrum (2×13C), and the 13C fractional enrichment was calculated from the ratio between 231 
this 13C related NMR spectrum and the non-edited (12C +13C) spectrum. Thus, this value is not related 232 
to the tissue weights and the extraction ratios, and the original peak integrations in the POCE spectrum 233 
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used for the analysis. 234 
Data analysis 235 
In this study, all rats were randomly assigned to the experimental procedures including housing 236 
and feeding. Single-factor analyses of variance were performed to determine the difference in the level 237 
of metabolites, 13C fractional enrichment in different positions of metabolites, and BBB scores. 238 
Differences of the amino acid levels and 13C fractional enrichments were identified with Student t-test 239 
with adjustment of p-value for Bonferroni correction. All results were presented by mean ± SEM. 240 
 241 
Results 242 
Basso, Beattie and Bresnahan (BBB) Locomotor Scale 243 
The BBB score was used to evaluate and compare the motor function and recovery of the animals 244 
in the chronic SCI treatment group with the chronic sham group. The BBB score for the chronic SCI 245 
group (n = 12) showed improvement with a mean initial score of 6.00 ± 0.84 in the first week which 246 
increased to a mean score of 15.08 ± 1.71 by the fourth week (Fig. 1). Based on the results of the 247 
comparison, the animal gradually recovered during the first three weeks, and reached the optimum 248 
level around the 3rd week. In addition, some of the rats had recovered well by the end of the 4th week 249 
(n=4). 250 
SCI leads to neurons death and glial cells activation 251 
In the sham group, the gray and white matter structures of the spinal cord are clear, the cells are 252 
evenly distributed and orderly arranged, neurons and glial cells are clearly visible, and no cavities and 253 
necrotic tissues are observable (Fig. 2). In the acute SCI group, the structure of the injury site is 254 
disordered, and the boundary between the gray matter and white matter of the spinal cord is unclear. 255 
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Cavities and necrotic tissues can be seen, neurons disappeared, and a large number of activated glial 256 
cells migrated into the lesion site, transforming into foam cells under phagocytosis (Fig. 2). Thus, the 257 
animal model for the SCI treatment was successfully constructed. 258 
POCE NMR Spectrum of brain extracts 259 
In order to evaluate the total concentrations of metabolites and metabolic kinetics in different 260 
brain regions, the POCE NMR pulse sequence was employed to investigate the metabolic 261 
compositions of the brain extracts in the current study. Here a typical series of POCE NMR spectra 262 
for four different groups are illustrated in Fig. 3. The relative concentrations of the metabolites were 263 
obtained from the PQN normalized non-edited spectrum (upper four spectra); and the total 264 
concentrations of 13C labeled metabolites were calculated by subtracting the two series of spectra in 265 
POCE data which are shown in the lower four spectra. 266 
Metabolites concentration in different brain regions after SCI 267 
To explore the changes of metabolites in different brain regions, which might be related to 268 
neurobehavioral abnormalities after SCI, the relative concentrations of metabolites in four different 269 
groups (Acute SCI vs. Sham (Acute); Chronic SCI vs. Sham (Chronic)) were compared among 11 270 
brain regions. After comparison, the concentrations of most metabolites did not change in these two 271 
pairs. For example, several metabolite concentrations (glutamate, GABA and aspartic acid (Asp)) are 272 
illustrated in Fig. 4. For these metabolites, there were only a few changes among 22 pair comparisons 273 
in each metabolite (two group pair × 11 brain regions). Glutamate was significantly decreased only in 274 
FC for the chronic SCI group (Fig. 4A, p=0.002). However, there were opposite changes observed for 275 
GABA in the cortex and deep brain areas, and GABA was increased in HYP (p=0.008) and TC 276 
(p=0.035, Fig.4B). Furthermore, there was an increase in Asp at regions of MED and HP (p=0.004 and 277 
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0.008, Fig. 4C). However, changes in metabolite concentration after SCI were similar in both acute 278 
and chronic groups. In order to pursue the influence of SCI on brain function, it was valuable to 279 
investigate the changes of the 13C enrichment in various metabolic positions for different groups during 280 
[1-13C]-glucose infusion. 281 
Metabolic 13C enrichments in different brain regions 282 
With the infusion of [1-13C]-glucose, different positions of metabolites were labelled via the 283 
tricarboxylic acid (TCA) cycles in GABAergic and glutamatergic neurons and astroglia cells. For the 284 
first TCA cycles in neurons, Glu4 (glutamatergic neuron) and GABA2 (GABAergic neuron) were 285 
labeled with 13C probe, and Gln4 was labeled in astroglia cells. Then the other carbon positions in 286 
metabolites were gradually labelled with further TCA cycles.  287 
For the acute SCI model, 13C enrichments in different positions of metabolites among most brain 288 
regions were decreased, especially for the cortex (FC, OC, PC and TC), MID, MED and HYP (Fig. 5, 289 
Fig. 6 and Fig. S1). After chronic SCI treatment, the metabolic kinetics in the cortex was recovered, 290 
especially for OC and TC (Fig. 5B and S1). However, the 13C enrichments in some regions were 291 
decreased, such as THA and CE (Fig. 6A and S1). In order to show the tendency of changes, 13C 292 
enrichment in different positions of metabolites for the cortex (FC and TC) and sub-cortex (THA and 293 
HP) are illustrated in the main text (Fig. 5 and Fig. 6), respectively. 294 
Most enrichment of 13C labeled amino acids from [1-13C] glucose in the prefrontal cortex of 295 
different groups exhibited significant changes. The 13C enrichments in Glu4 (p=0.037), Asp3 (p=0.028), 296 
GABA3 (p=0.048) and Glx3 (p=0.046) in the acute SCI group were found to be significantly lower 297 
than in the acute sham group. In addition, Glu4 (p=0.011), Asp3 (p=0.001), Glu3 (p=0.023), GABA3 298 
(p=0.016), Glx2 (p=0.023) and Ala (p=0.001) in the chronic SCI group was also found to be 299 
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significantly different from the chronic sham group (Fig. 5A). For the temporal cortex, there were only 300 
significant differences observed in the acute SCI group, such as Glu4 (p=0.029), GABA3 (p=0.035), 301 
Asp3 (p=0.004), Glu3 (p=0.016), Glx3 (p=0.022) and Glx2 (p=0.026), and only Glu4 (p=0.043) in the 302 
temporal cortex dramatically changed in the chronic SCI group (Fig. 5B). 303 
Compared with the acute SCI treatment, THA had more fractional 13C enrichment in different 304 
types of metabolites in the chronic SCI group, such as Glu4 (p=0.005), GABA4 (p=0.005), Asp3 305 
(p=0.001), GABA3 (p=0.033), Glx3 (p=0.018), Glx2 (p=0.011) and Ala3 (p=0.01). However, only Glu4 306 
(p=0.047) and Gln4 (p=0.047) were decreased in the acute SCI group (Fig. 6A). The enrichments of 307 
Glu4 and Gln4 were significantly decreased in the hippocampus in both groups (Fig. 6B). 308 
 309 
Discussion 310 
SCI is defined as damage to the spinal cord which temporarily or permanently causes changes in 311 
its structure and function, and the structural dysfunction can induce the changes of metabolic activity 312 
in the central nervous system. The cerebral regional effects on the metabolic information are also 313 
known to be closely associated with changes in the cerebral structure and function. 314 
Metabolite concentrations and SCI 315 
Alternations of metabolic information have been used as biological markers for more widespread 316 
physiological changes in the brain and SCI site. Recent studies have described metabolic changes in 317 
cortical activation during sensory and/or motor tasks in cervical myelopathy and patients with SCI (7, 318 
32). It has been shown that the levels of NAA (N-acetyl-aspartic acid), Cr (Creatine), Ins and Glu were 319 
increased in the thalamus/striatum of rats after SCI (33). However, another study reported that NAA 320 
and GABA levels were reduced in the thalamus of SCI patients with neuropathic pain compared to 321 
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those without pain and healthy controls (34). The current study also focused on examining the 322 
metabolite changes in different brain regions after SCI. However, there were few changes in metabolic 323 
concentrations in most brain regions which is not consistent with former findings. Compared with 324 
previous work, the current 1H-NMR method used has much higher signal to noise value than the in 325 
vivo MRS approach (33, 34). Furthermore, the tissue volume detected by the in vivo MRS method is 326 
always standard cuboid or square shapes, which is not consistent with the real shape of the brain region. 327 
In this study, the cerebral regional tissues were dissected and the metabolites extracted and measured 328 
using the 1H-NMR method which is more accurate compared to the in vivo method. 329 
 330 
Metabolic kinetics and SCI 331 
In general, the metabolic kinetics in most brain regions were significantly decreased in both acute 332 
and chronic groups. Thus, SCI was observed to exert significant effects on the TCA cycle, which 333 
mainly occurs in mitochondria, and generates ATP and metabolites for survival and growth (35). 334 
Mitochondria dysfunction in the brain always occurred during acute SCI, followed by the 335 
inflammatory response and ER stress aroused in the subacute phase (36), which plays a key role in the 336 
development of secondary pathophysiology after contusion SCI (37). The results highlight an acute 337 
and chronic deficit in mitochondrial bioenergetics associated with SCI that may lead to a novel 338 
approach for neural restoration after SCI. 339 
With different methods targeting mitochondria dysfunction, multiple groups have reported that 340 
this yields neuroprotection, tissue sparing, and functional recovery (38, 39). Mitochondrial 341 
transplantation is emerging as a potential therapeutic to maintain mitochondrial function after injury, 342 
consequently improving chronic functional outcome (40). Although this therapy is relatively new, 343 
17 
 
mitochondrial transplantation is effective in promoting recovery after ischemic injury to cardiac tissue 344 
(41). Many pharmacological agents that have proven beneficial for the treatment of SCI in vivo to 345 
some extent affect mitochondria or mitochondrial function (39). For example, the antibiotic 346 
minocycline was found to have neuroprotective effects and induced behavioral and cellular recovery 347 
after SCI in rats (42). NACA treatment significantly maintained acute mitochondrial bioenergetics and 348 
normalized GSH levels following SCI, and the prolonged delivery resulted in significant tissue sparing 349 
and improved recovery of hindlimb function (43). 350 
 351 
Regional effects and SCI 352 
The metabolic information, required to determine metabolic fluxes, commonly vary with cerebral 353 
regions as shown in the human (44), rat (45) and mouse (46) brains. Both the cerebral cortex and deep 354 
brain regions have their own variation characteristics after SCI. Comparisons of metabolic enrichment 355 
in the cerebral cortex, thalamus and hippocampus revealed substantial and highly significant regional 356 
variations (Fig. 5 and 6). 357 
In previous studies, the cerebral cortex was selected as a whole region in order to compare 358 
regional changes in metabolite concentrations (45). However, the regional cerebral effects on 359 
metabolic information in the brain cortex after SCI have been little studied. The present study revealed 360 
changes in different brain cortices and showed distinct variations of metabolic kinetics in the cortex. 361 
The frontal cortex showed that the 13C enrichment in neurotransmitters were markedly decreased in 362 
both chronic and acute groups. However, the impact of SCI on the TC (Fig. 5B) and OC (Fig. S1B) 363 
were mainly significantly decreased in the acute group (Fig. 5), and the alterations were mostly 364 
recovered after long-term recovery. A greater understanding of how sensory-motor function reorganize, 365 
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both spontaneously after injury and in response to therapeutic interventions, is necessary in order to 366 
develop repair strategies that maximize function and are readily translatable to clinical practice. It has 367 
recently been shown that, in humans, physiotherapy can improve neurocognitive deficits associated 368 
with SCI (47). From the finding in the present study, it could be proposed that metabolic changes in 369 
cortical regions (sensorimotor) reasonably overlap with the ones positively affected by physiotherapy 370 
in humans. Thus, the present study offers an animal-based neurophysiological explanation of a 371 
behavioral effect observed in humans. Furthermore, this study also provides the neurophysiology-372 
based understanding for designing brain–machine interfaces that could restore the lost motor function 373 
for improving rehabilitation (48).  374 
The reorganization observed at the cortical level could also occur at the subcortical level (49). 375 
Nonetheless, subcortical reorganization could in principle occur either in the thalamus (50) or 376 
brainstem (51). The thalamus plays a central role in modulating the selection, execution, modification 377 
of motor programs, nociception and almost all sensory modalities (52). The changes after SCI lead to 378 
the reorganization of the thalamus (53). The present study revealed changes in the thalamus that 379 
showed a higher TCA cycle flux compared with the hippocampus, which suggests distinct kinetics in 380 
the rat. The 13C enrichment amino acids in the thalamus mainly decreased in the chronic group, while 381 
only Glu4 and Gln4 were significantly decreased in the acute group, which might indicate that SCI in 382 
rats could produce lasting deficits in thalamus metabolism.  383 
 384 
Neuronal types and SCI 385 
The impact of SCI on excitatory transmitters (Glu) was greater than on inhibitory 386 
neurotransmitters (GABA) in most brain regions, especially for the acute SCI group (Cerebral 387 
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alterations -Fig. 5, 6 and S1: 9 regions for Glu4 and 2 regions for GABA2). Glutamate and glutamine 388 
are relatively abundant amino acids in the brain that are critical for neuronal function (54), and they 389 
were involved in the regulation of brain energy metabolism (18). A dysfunction in the homeostasis, 390 
recycling, and metabolism of glutamate also participates in the course of many chronic 391 
neurodegenerative diseases (18). Alteration of this cyclic nature of Glu and Gln has been shown to 392 
play an important role in the regulation of various neurological disorders, including epilepsy, multiple 393 
sclerosis, traumatic brain injury, schizophrenia, and brain tumors (55).  394 
Neuropathic pain after SCI was also reported to be always associated with altered thalamic 395 
anatomy, biochemistry, and activity, which may result in disturbed thalamocortical circuits (34). The 396 
glutamatergic metabolism, glial proliferation, glial hypertrophy, or activation might be factors 397 
contributing to intense neuropathic pain after SCI (34). There is no doubt that unbalanced metabolism 398 
of neurotransmitters may be involved in the process of neuropathic pain. Specifically, it has been 399 
shown that neuropathic pain after SCI is associated with changes in thalamic neurons, which 400 
subsequently may make these neurons hyperexcitable, and as such, may act as a pain generator or 401 
amplifier (56). Hyperexcitability also plays a role in the genesis of multi-sensory symptoms after SCI, 402 
this might either be a common phenomenon across different sensory cortices, or one might postulate 403 
hyperexcitability within a structure with sensory input to the thalamus. Thus, the current study 404 
speculates that the glutamatergic activity could be related to neuropathic pain caused by SCI, which 405 
could provide an avenue for the clinical therapy of SCI. 406 
 407 
Conclusion 408 
In this report, the metabolite levels were almost similar in every cerebral region during the 409 
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different stages of SCI, but the metabolic kinetics (13C fractional enrichment in different carbon 410 
positions of metabolites) were significantly lower in most regions, especially the frontal cortex, 411 
parietal cortex, hippocampus, thalamus, and hypothalamus in both acute and chronic SCI groups. After 412 
long-term recovery, some metabolic kinetics were recovered, especially in the temporal cortex, 413 
occipital cortex and medulla. Furthermore, the impact of SCI on excitatory transmitters (Glu) was 414 
greater than on inhibitory neurotransmitters (GABA) in most brain regions, especially for the acute 415 
SCI group. The changes in metabolic kinetics revealed that the alteration in metabolism and 416 
neurotransmission in different brain regions could present evidence for the alternation of brain glucose 417 
oxidation after SCI. Therefore, SCI significantly influenced the cerebral function, especially for acute 418 
intervention. 419 
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Figure legends: 628 
Fig. 1: Assessment of motor recovery on chronic SCI rats (n=12 for every group) assessed by BBB 629 
scores over four weeks. Note: The scores indicate that the chronic SCI group showed significant 630 
improvement over the Sham group (p=0.0071). Statistical analysis was performed with one-way 631 
ANOVA involving multiple comparisons, **p＜0.01; Different lowercases mean there was significant 632 
difference among different period comparisons in the chronic SCI treatment. 633 
 634 
Fig. 2: HE and Nissl staining of the spinal cord (horizontal and transverse sections) after SCI. 635 
 636 
Fig. 3: NMR spectra for total metabolites (12C+13C, upper) and 13C related metabolites (2*13C, lower) 637 
from the POCE (1H observed/13C edited) NMR spectra for the frontal cortex. Note: subscript: proton 638 
signal connected with the 13C position in the metabolites; Asp: Aspartate; Gln: glutamine; Glu: 639 
glutamate; Glx: glutamine + glutamate; GABA: γ-aminobutyric acid; Cre: Creatine; NAA: N-640 
acetylaspartate. 641 
 642 
Fig. 4: The relative concentrations of metabolites in 11 different brain regions for four different groups 643 
(Sham (Acute):12; Acute SCI: 11; Sham (Chronic): 10; and Chronic SCI: 12). Note: (A): Glutamate, 644 
(B): GABA, (C): Aspartic acid; Values represent mean ± SEM; *p＜0.05, **p＜0.01. 645 
 646 
Fig. 5: The 13C fractional enrichments in different kinds of metabolites from [1-13C] glucose in the 647 
frontal cortex (A) and temporal cortex (B) for four different groups. Note: Values represent 648 
mean±SEM.*p＜0.05, **p＜0.01; C2-C4: proton signals connected with the related 13C positions (2-649 
4) in the metabolites. 650 
 651 
Fig. 6: The 13C fractional enrichments in different kinds of metabolites from [1-13C] glucose in the 652 
thalamus (A) and hippocampus (B) for four different groups. Note: Values represent mean ± SEM.*p653 
＜0.05, **p＜0.01; C2-C4: proton signals connected with the related 13C positions (2-4) in the 654 
metabolites. 655 
